FY2026 · ended Mar 31, 2026 · Revenue $403.43B, +12.4% YoY · Filed May 8, 2026
McKESSON CORPORATION (MCK) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $403.4 billion and net income of $4.8 billion. Free cash flow was $5.7 billion. As of Sep 30, 2026 it held $6.5 billion in cash and investments and $11.2 billion in total debt.
Revenue (TTM)
$418.79B
+8.2% vs year-ago TTM
Net income (TTM)
$4.70B
+16.5% vs year-ago TTM
Operating cash flow (TTM)
$7.50B
+9.3% vs year-ago TTM
Free cash flow (TTM)
$7.11B
+11.8% vs year-ago TTM
EPS (TTM)
$38.97
+21.3% vs year-ago TTM
Dividend per share (TTM)
$3.40
+15.3% vs year-ago TTM
Shares outstanding
120.20M
-3.9% vs prior year
Net cash
$-4.63B
as of Sep 30, 2026
Operating margin
1.6%
FY 2027
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MCK (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Irving, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927653
- Former names
- MCKESSON HBOC INC (until Aug 13, 2001)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $403.4B | $359.1B | $309.0B | $276.7B | $264.0B |
| Operating income | $6.2B | $4.4B | $3.9B | $4.4B | $2.0B |
| Net income | $4.8B | $3.3B | $3.0B | $3.6B | $1.1B |
| Diluted EPS | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 |
| Operating cash flow | $6.2B | $6.1B | $4.3B | $5.2B | $4.4B |
| Free cash flow | $5.7B | $5.5B | $3.9B | $4.8B | $4.0B |
| Total assets | $82.3B | $75.1B | $67.4B | $62.3B | $63.3B |
| Stockholders' equity | -$2.2B | -$2.1B | -$2.0B | -$1.9B | -$2.3B |
| Cash and investments | $4.0B | $5.7B | $4.6B | $4.7B | $3.5B |
| Total debt | $8.8B | $7.6B | $7.6B | $7.5B | $7.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2026 | Aug 25, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1007 McKESSON CORPORATION SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.